相关实验视频
Updated: Jul 12, 2025

10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
2.4K
微RNA,长非编码RNA,圆形RNA和妇科癌症:专注于转移
Aryan Rezaee1, Sara Ahmadpour2, Ameneh Jafari3
1Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Frontiers in oncology
|October 19, 2023
概括
非编码RNAs (ncRNAs) 显著影响妇科癌症转移. 了解它们在卵巢,宫和子宫内膜癌中的作用是改善患者存活率的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 妇科癌症,包括卵巢,宫和子宫内膜类型,是全球女性癌症死亡的主要原因.
- 瘤转移,即癌症扩散到周围组织,是死亡的主要原因.
- 非编码RNAs (ncRNAs) 越来越多地被认为是它们在癌症进展和转移中的作用.
研究的目的:
- 审查三种主要ncRNA类型 (长非编码RNA,微RNA,圆形RNA) 在妇科癌症转移中的特定作用.
- 阐明ncRNAs通过分子途径和相互作用影响卵巢,宫和子宫内膜癌的侵袭和转移的分子途径和相互作用.
- 突出了解ncRNA功能的重要性,以改善患者的治疗结果.
主要方法:
- 文献综述侧重于最近关于ncRNAs和妇科癌症转移的研究.
- 对详细说明长非编码RNA,微RNA和圆形RNA参与的研究进行分析.
- 关于卵巢,宫和子宫内膜癌转移的分子途径和细胞相互作用的信息合成.
主要成果:
- ncRNAs在调节妇科癌症的侵袭和转移方面发挥着多样化和关键的作用.
- 特定的ncRNAs影响关键的细胞过程,如血管生成和上皮细胞-介质细胞过渡.
- 已识别的分子通路为推动妇科癌症传播的机制提供了洞察力.
结论:
- 非编码RNAs是妇科癌症转移的关键调节者.
- 准ncRNA通路是对抗妇科癌症进展的潜在治疗策略.
- 对ncRNA功能的进一步研究对于开发新型治疗方法和提高生存率至关重要.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
The Nucleolus
8.9K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K
piRNA - Piwi-interacting RNAs
6.9K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.9K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K

